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Abstract
The Mutant Mouse Resource and Research Center (MMRRC) Program is the pre-eminent public national mutant mouse
repository and distribution archive in the USA, serving as a national resource of mutant mice available to the global scientific
community for biomedical research. Established more than two decades ago with grants from the National Institutes of Health
(NIH), the MMRRC Program supports a Consortium of regionally distributed and dedicated vivaria, laboratories, and offices
(Centers) and an Informatics Coordination and Service Center (ICSC) at three academic teaching and research universities and one non-profit genetic research institution. The MMRRC Program accepts the submission of unique, scientifically
rigorous, and experimentally valuable genetically altered and other mouse models donated by academic and commercial
scientists and organizations for deposition, maintenance, preservation, and dissemination to scientists upon request. The four
Centers maintain an archive of nearly 60,000 mutant alleles as live mice, frozen germplasm, and/or embryonic stem (ES)
cells. Since its inception, the Centers have fulfilled 13,184 orders for mutant mouse models from 9591 scientists at 6626
institutions around the globe. Centers also provide numerous services that facilitate using mutant mouse models obtained
from the MMRRC, including genetic assays, microbiome analysis, analytical phenotyping and pathology, cryorecovery,
mouse husbandry, infectious disease surveillance and diagnosis, and disease modeling. The ICSC coordinates activities
between the Centers, manages the website (mmrrc.org) and online catalog, and conducts communication, outreach, and
education to the research community. Centers preserve, secure, and protect mutant mouse lines in perpetuity, promote rigor
and reproducibility in scientific experiments using mice, provide experiential training and consultation in the responsible
use of mice in research, and pursue cutting edge technologies to advance biomedical studies using mice to improve human
health. Researchers benefit from an expansive list of well-defined mouse models of disease that meet the highest standards
of rigor and reproducibility, while donating investigators benefit by having their mouse lines preserved, protected, and distributed in compliance with NIH policies.
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Accelerating the use of mutant mice
in biomedical research
Beginning in the early 1990’s, a nearly three decade
expansion of the repertoire of mouse models that could be
used experimentally for the study of human diseases began
(Davisson and Taft 2006; Gurumurthy and Lloyd 2019).
Sequential emergence and experimental application of a
myriad of technologies, including ethylnitrosurea (ENU)
mutagenesis, homologous recombination in embryonic
stem (ES) cells, transgenic, conditional targeting (e.g.,
Cre), transposons, and programmable endonucleases
(e.g., CRISPR/Cas9) all contributed to a rapid growth in
the design, development, and production of a variety of
mutant mice for biomedical research. Eventually, the few
commercial and not-for-profit mouse distributors that were
archiving and maintaining these new mouse lines were
becoming overwhelmed, precipitating risky and capricious trafficking of mice among individual investigator
laboratories, often with naive disregard of quality control
standards, genetic fidelity, contamination with adventitious
pathogens, or the spread of transmissible infections. As
a consequence, many mouse lines were unavailable or if
available unaccessible, and those that could be obtained
were often unreliable due to poorly characterized and
often erroneous genotype, insufficient documentation, or
poor health. In turn, results published using these models failed replication, preclinical research using animals
became unpredictable and irreproducible, and scientific
progress was being hampered. These and other challenges
were spreading widely, and the reliability and reproducibility of scientific results using mice (and other animals)
was being seriously questioned, especially in translational
preclinical studies (Kilkenny 2009).

A trans‑national network of non‑profit
mouse repositories
In response to these mounting pressures, the US National
Institutes of Health (NIH) in 1998 convened a panel of
internationally renowned scientists to draft recommendations for facilitating broad but controlled access to mouse
resources under rigorous quality control standards (Battey
1999). The top recommendation of this group was for the
federal government to create a consortium of archive and
distribution repositories to solicit, accept, import, validate,
maintain, preserve, and disseminate mutant mouse lines,
especially those generated by NIH-funded researchers
and laboratories. Although expected to have the scientific
expertise, experience, capability, and capacity to manage
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mice and mouse resources, NIH-supported repositories
were first and foremost tasked with serving as an unrestricted resource of the burgeoning mutant mouse lines
for experimental use by the academic research community.
Second, they were mandated to contribute to science and
technology to enhance and develop their holdings, such
as research into embryo cryopreservation and archiving
frozen germplasm. Third, repositories were to serve the
broad research community in diverse disease areas, and
not focus on a particular category of mouse resource or
disease area. Fourth, they were to make mice available to
the research community on a local, regional, and national
(and eventually international) basis, irrespective of where
the repositories were located geographically. Finally,
funded repositories were expected to have robust animal
infrastructure (vivaria, technicians, veterinary and laboratory support), mouse husbandry and care experience,
and infectious and genetic quality control and assurance
standards and policies in place to ensure research reproducibility and integrity. These characteristics have since
become fundamental expectations of centralized mouse
repository systems worldwide (Donahue 2012).

Birth of the MMRRC
What arose from these discussions was the creation by
NIH of an extramural Mutant Mouse Regional Resource
Center (MMRRC) Program which was intended to fund
competitive applications from public and private entities
committed to accepting, maintaining, and disseminating
mutant mouse models to the biomedical research community (Grieder 2002). The first Request for Applications
(RFA-RR-99-001) was issued by the NIH National Center
for Research Resources (NCRR; now under the authority of
the NIH Office of Research Infrastructure Programs [ORIP],
Division of Program Coordination, Planning, and Strategic
Initiatives [DPCPSI], Office of the Director) which officially
established the MMRRC Program as the nation’s premier
publicly accessible mutant mouse archive and distribution repository system. The MMRRC was rechristened in
2014 as the Mutant Mouse Resource and Research Center
to reflect the expansion of its mission to include resourcerelated research that is intended to promote greater effectiveness and efficiencies in service to the biomedical research
community without bias for a particular category of mouse
model or research. In practical terms, the MMRRC Program
provided funding to host institutions willing to participate
in a national Consortium of individual, regionally distributed Centers with dedicated infrastructure (including barrier housing and microbial quality control), cryopreservation
and reconstitution capabilities, proven standard operating
procedures (SOPs) and surveillance protocols for infectious
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pathogens and environmental contaminants, and sufficient
professional, scientific, and technical expertise in quality
control and other activities to maintain the genetic integrity
of mice and germplasm at first, then later murine embryonic
stem (ES) and hybridoma cell lines.
The first NIH awards establishing archive and distribution
Centers were made in 1999, two to academic institutions
(UC Davis and UNC-Chapel Hill) and two to commercial/
academic partnerships (Harlan/University of MissouriColumbia and Taconic/SUNY-Albany) which together with
a separately funded Informatics, Coordination and Service
Center (ICSC) collectively became known as the MMRRC
Consortium. At the first competitive renewal in 2005, the
two commercial partners had left the MMRRC Consortium
while funding was awarded to the University of MissouriColumbia to operate alone as the third Center. In response to
the growth and success of the three academic-based Centers
during the first 10 years of funding, at the 2nd competitive
renewal in 2010 The Jackson Laboratory was added as the
fourth Center. All four Centers then successfully renewed
in 2015 and again in 2020. Today, each Center exists in
a research-intensive environment that synergizes with inhouse genetic and programmatic resources and expertise
that reinforces the MMRRC Program mission (Table 1)
and engages in close coordination and working relationship
between Centers.
The original mandate of the Centers participating in the
MMRRC Consortium was to accept, maintain, and distribute mutant mice to the scientific community. This approach
would ensure the viability, genetic identity and background,
pathogen-free status, and long-term availability of valuable
mutant mouse models for research. The four Centers operate
under a common umbrella of SOPs that define best practices
Table 1  Location and web addresses of (current) Centers in the
MMRRC Consortium
Host Institution (year established)

Web Address

University of Missouri, Columbia (1999*)
University of California, Davis (1999)
The Jackson Laboratory (2010)
University of North Carolina, Chapel Hill
(1999)

mmrrc.missouri.edu
mmrrc.ucdavis.edu
jax.org/mmrrc
med.unc.edu/mmrrc

*Initially in partnership with Harlan, then established independently
2005

Table 2  MMRRC consortium
best practices

for the operation of a twenty-first century mouse archive and
distribution repository system (Table 2).
Centers harmonized internal SOPs within the MMRRC
Consortium while maximizing individual efficiencies. The
Centers began serving as centers of excellence in mouse
biology and phenotyping, thereby facilitating and extending the validity, reproducibility, and scientific value of these
models. In some cases they have also earned “approved
vendor” status from institutions of requesting investigators,
facilitating direct import of mice into research colonies
which bypasses costly delays associated with importation
quarantines and rederivation.

Opening its doors for business
When launched, Centers within the MMRRC Consortium
began accepting applications from investigators to submit
their mutant mouse lines for archiving and distribution. It
was at this time that the variety and types of mouse lines…
from those derived from ethylnitrosurea (ENU) injection
into male mice, random gene and promoter trap experiments in murine ES cells, mice expressing specific recombination enzymes (CRE, FLP), to a host of new transgenic
and knockout mice. Within a year, the MMRRC Program
was adapting to this changing environment and broadening
opportunities for acceptance of a wider variety of mouse
lines by establishing three types of submissions (Table 3).
Most submissions were categorized as Type 1 in which a
mutant mouse line was developed and characterized by the
donating investigator. Type 1 submission applications are
reviewed monthly by video teleconference of a Coordinating Committee made up of the principal investigators of the
Centers and ICSC and NIH program officials. These reviews
are intended to determine whether an application for a Type
1 submission fulfills the following six criteria:

Table 3  Types of mouse submissions to the MMRRC Program
MMRRC donation type

Description

Type 1
Type 2
Type 3

Individual donating investigators
NIH Program Officer-sanctioned mice/lines
Contract to individual center

All MMRRCs observe best practices in the following activities:
Importation, rederivation, maintenance (e.g., husbandry, care, and welfare), and distribution
Cryopreservation and recovery, pathogen surveillance and health monitoring, mouse genetics
Information technology, database management, and website and online services
Communications, outreach, and education
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•
•
•
•

from other publicly available lines;
Exhibits scientifically rigorous and experimentally reproducible findings;
Exists at no other public distribution repository;
Available for distribution without restriction to academic
researchers, and
Controls are readily available or can be provided by the
submitting investigator.

Cumulative
(2000–
2020)

Type 1: Investigator initiated, MMRRC Program supported
Type 2: NIH initiated, MMRRC Program supported
Type 3: Investigator initiated and supported
Totals

1872
234
57,796
59,902

Cumulave Increase in Number of MMRRC Holdings
2002-2021
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Although not required, a scientific publication or readily
accessible phenotype data (e.g., via a web-based resource)
describing the creation and study of the submitted mouse
line adds considerable scientific data and documented evidence to facilitate review. Generally, a mouse line must meet
all criteria to be accepted into the MMRRC. Upon review,
MMRRC ICSC staff will work with the submitting investigator to obtain additional details or provide other options
for depositing into the MMRRC (e.g., Type 3 donation)
if their mouse line fails to meet acceptance criteria. The
only cost to the submitting investigator is that incurred by
shipping mice to the assigned Center. Other than that, all
importation, rederivation, quality control testing, maintenance, and archiving costs are borne by NIH funds awarded
to the host institution to support the Center. For example,
once imported into the Center’s repository, tissue samples
are taken for DNA extraction to confirm genotype of the
mutant allele and genetic background, fecal pellets are harvested (or collected earlier by the submitting investigator
before shipping mice) for microbiome analysis, mice are
bred (if necessary) to generate live colonies, and sperm and/
or embryos are cryoarchived. Mice are listed as available
for distribution by browsing or searching the online catalog
once fully curated and after confirmation of gene-specific
genotype and genetic background, establishment of a cryopreserved archive and verification of viable cryorecovery,
determination of pathogen-free status, and exclusion of unintended or contaminating DNA elements (e.g., Cre). Proceeds
derived from modest fees charged to requesting investigators
to obtain and ship mouse lines to requesting investigators
provides program income to support distribution costs (e.g.,
cryorecovery supplies, technical effort, genotyping, holding
costs, etc.) incurred by the Center.
Type 2 and Type 3 submissions undergo a similar level
of rigorous assessment and review yet because of their origin or other special characteristics do not go through the
same formal application process as Type 1 submissions.
For example, the MMRRC Program provides a very limited
number of Type 2 submission “slots” that are pre-selected
by NIH categorical institutes for fast-track acceptance of
mice from their funded scientists into the MMRRC. Type 3

Table 4  Mutant mouse lines accepted into the MMRRC Program

Number of Unique Alleles

• Created and analyzed using sound scientific methods;
• Distinguishable genotypically and/or phenotypically

Fig. 1  The cumulative annual increase in MMRRC Program holdings
of unique mutant alleles and hybridoma cell lines beginning in 2002
to March 1, 2021. The change each year reflects the sum of all submissions (Type 1, Type 2, and Type 3) accepted and imported into the
MMRRC repositories during that year

submissions are primarily secured as large, thematic collections that were produced by large consortiums, commercial
organizations, and/or private research entities. Some of these
collections are submitted and made available for distribution as gene-targeted ES cells, several of which have been
converted into mice and are available as frozen germplasm.
As a result, over time the number of Type 3 mouse lines has
significantly exceeded the number of either Type 1 or Type
2 mouse lines deposited into the MMRRC (Table 4).

Donation of mouse lines to the MMRRC
The growth in number of holdings in the MMRRC Program
has increased over the last 20 years to a total of 60,751
unique mutant alleles (Fig. 1), making it one of the largest public repositories of mutant mouse lines in the world
today. These lines are available in one of more forms as live
mice, frozen germplasm, and/or pluripotent ES cell lines or
hybridomas (Fig. 2). These models are useful for research
in many disease categories including oncology, cardiology,
immunology, and neurology, developmental biology, and to
study specific syndromes and diseases. Investigators interested in submitting their mouse line to the MMRRC Program can submit information online through the MMRRC
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Proporon of MMRRC Holding Formats
(as of 2021)
Number of Unique Researchers

Cryopreserved Germplasm(1)

Cells(2)

Fig. 2  The proportional distribution of various formats (live, cryopreserved germplasm, cell lines) for all MMRRC holdings as of 2021.
The number of mouse lines maintained as live breeding colonies is
small relative to the germplasm and cell archives and reflects those
lines undergoing active importation and awaiting cryopreservation
and/or being actively distributed in response to orders for live mice;
(1) a mutant allele maintained as a frozen embryo and/or sperm; (2)
embryonic stem cells or hybridoma cell lines
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The number of researchers using the MMRRC Program and
the number of orders for mutant mouse lines have steadily increased since the MMRRC Consortium started operations. For example, the number of unique users has averaged
over 1276 per year over each of the last 5 years to a total
of 16,303 by the end of 2020 (Fig. 3). Despite the recent
and temporary drop in orders resulting from the impact of
the global SARS-CoV-2 pandemic on research activity and
onsite laboratory work during most of 2020, this number
of users has translated into a substantial number of orders
received and fulfilled overtime by the MMRRC since opening its doors (Table 5). Many researchers are returning customers who request not only additional mouse lines but also
special services from a Center through their host institution.
In addition, with the implementation of a system of unique
Research Resource Identifiers (RRID; https://scicrunch.org/
resources) (Bandrowski and Martone 2016) to search relevant databases (e.g., PubMed), at least 1924 research articles
have been published to date using mouse lines obtained from
the MMRRC Program (Fig. 4). This number of publications
is surely an underrepresentation, as past publications often

1000

20

Distribution of mouse lines from the MMRRC

1200

20

website (https://www.mmrrc.org/submission/strain_submi
ssion_t erms.p hp), contact the Strain Acquisition Coordinator
at the ICSC, or contact the Import Coordinator at any of the
Centers for more information, assistance, and instructions.

1400

Fig. 3  The number of unique researchers annually who ordered from
the MMRRC repositories each year between 2015 and 2020. The sudden dropoff of orders during 2020 has been attributed to the effects of
the temporary shutdown of non-essential research activity and shuttered research laboratories during the SARS-CoV-2 pandemic

Number

Live Mice

Annual Number of Unique Users of the MMRRC
2015-2020

1600

Fig. 4  Annual number of peer-reviewed publications that cite or
acknowledge ordering mice, germplasm, or cell lines from the
MMRRC repositories between 2008 and 2020. As of March 1, 2021,
a total of 1,924 publications have cited or acknowledge the use of
the MMRRC. Unfortunately, because not all reseachers who publish
remember to cite usage of the MMRRC, these numbers underrepresent the actual number of publications reporting on the use of mice,
germplasm, or cell lines obtained from the MMRRC repositories

Table 5  Orders for mutant
mouse lines from the MMRRC
Program

Metric

Cumulative
2000–2020

Orders1
Investigators2
Institutions2

13,184
9591
6626

1

Can include multiple mouse
lines mice

2

Unique

neglect to cite the MMRRC. New articles are discovered
daily, reflecting the ongoing importance of the MMRRC
Program as a vital public resource for research using mutant
mice.
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Enhancing capacity to improve resource
quality

Coordination between centers in the MMRRC
consortium

As experts in mouse biology and related research, each
Center also provides a number of ancillary services and
procedures that can be accessed by users of the MMRRC.
These services include colony management and breeding,
assisted reproductive technologies, ES cell and microinjection, transgenic and other production (CRISPR/Cas9)
approaches, genotyping and genetic analysis, in vivo and
ex vivo phenotyping, clinical diagnostics, and anatomic
pathology. Individuals, institutions or consortia may
arrange for the acquisition, importation, cryopreservation
and distribution of individual mouse lines or collections
on a fee-for-service basis from a Center. A table of available services and contact information at each Center can
be found at https://www.mmrrc.org/about/members.php

Centers and ICSC PIs in addition to meeting monthly convene with NIH program staff annually in person to discuss complex programmatic and strategic planning, allowing time to critically and objectively review and assess
consortium-wide operational and performance metrics,
discuss research goals and accomplishments, and develop
strategies to address the evolving needs of the biomedical research community. Biennially these meetings are in
association with the NIH-ORIP Resource Directors’ Meeting in Bethesda, Maryland. On alternate years, individual
Centers host MMRRC Consortium meetings at their host
institutions. An External Advisory Committee of five technical specialists and research scientists attend and provide
critical review and valuable feedback on MMRRC Program performance and planning to which the MMRRC
Consortium responds with action items and point-bypoint reports. These individuals also serve to represent
the scientific community and advise Center leadership on
ways to enhance and improve the provision and delivery
of services to its users. In addition, the MMRRC Consortium has established a number of internal working groups
which facilitate collective discussions to address issues,
challenges, and opportunities in management, administration, technology, intellectual property, research, and other
areas that help the MMRRC Program continue to evolve
and develop to effectively meet the needs of the research
community.

Conducting resource‑related scientific
research
A critical component of the MMRRC Program is innovative research that enhances resource operations and services,
such as developing optimal and more efficient means of
cryopreservation, re-animation, genotyping, infectious disease control, and microbiome analysis. These efforts have
included improvements in cryopreservation and recovery of
C57BL/6J and C57BL/6N sperm and embryos (Li 2014;
Mochida 2012), refinement of in vitro fertilization (IVF)
and intracytoplasmic sperm injection (ICSI) procedures (Li
2015,2003), enhanced isolation, purification, and gene targeting in murine ES cells (Pettit 2009), development of highdensity SNP genotyping panels (Mouse Universal Genotyping Arrays [MUGA]) to define genetic background and for
speed congenics (Sigmon 2020), improved pathogen detection assays (Ericsson 2017), genome editing technologies
(CRISPR/Cas9) (Modzelewski 2018) and the establishment
of strategies by which to provide requesting investigators
with mice on select complex microbiota (Hart 2018; Ericsson et al. 2017). In this way, the MMRRC Program is constantly adapting to the rapidly changing needs of the scientific community by mitigating negative impacts of growing
mouse populations on the nation’s infrastructure. Further,
electronic networking and innovative data management that
enables integration of data and information from multiple
sites, automated tools, curation, attention to cybersecurity,
and quality control have been incorporated by the ICSC into
the MMRRC Consortium. Centers provide training and professional expertise to maximize their impact and access by
the scientific community.

13

An emphasis on serving scientific needs
A primary goal of the MMRRC Program is to present a
single, unified, online presence to best serve its customers.
The ICSC coordinates customer service by maintaining a
public web site (www.mmrrc.org) with access to a searchable repository catalog, an ordering and submission system, and centralized customer service support. Customer
service staff at the ICSC are knowledgeable on all aspects
of MMRRC Program services. Customers can communicate with customer service staff through dedicated MMRRC
telephone numbers (800-910-2291 [North America], 530757-5710 [international]), email addresses (servic e@m
 mrrc.
org, suppor t@mmrrc.org), and a service request tracking
system. Standard customer operating procedures, including
templates and institutional tracking of intellectual property
issues, support both donors and purchasers and their affiliated research institutes as well as facilitate seamless coordination between all Centers in the MMRRC Consortium.
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Unified community outreach and education
The MMRRC promotes a unified identity to increase
awareness of mouse resources within the research community. The MMRRC brand is used across all outreach
materials, such as the MMRRC booth which ICSC staff
take to scientific meetings, print and online advertisement,
and pamphlets, buttons, and other collateral distributed at
meetings and within outgoing shipments. The MMRRC
Program is continuously developing new promotional
methods to build awareness of its repository holdings and
value-added services. Although together the Centers house
a large number of mouse lines with a variety of phenotypes, usage depends completely on customer awareness.
The ICSC profiles researchers based on their publications
and correlates research interests with repository holdings. This information is then distributed through highly
customized emails to inform researchers of specific and
potentially useful mice and services for their research. The
same system is used to solicit the submission of newly
published mouse models. The immediate success of this
system has been demonstrated by an increase in number
of strain submissions, flow of traffic to the MMRRC web
site, and volume of catalog searches. Comprehensive tools
for assessing the impact of email campaigns are utilized
to enhance their efficacy and to facilitate customer service
support. Interested investigators can follow the MMRRC
Program @mmrrc.

Enagagment and interaction
with complementary organizations
The MMRRC Program actively pursues opportunities
to engage and interact with similar and complementary
resources and entities. For example, the ICSC offers
openly available, automatic updates of the mouse holdings at each Center. Popular subscribers include PubMed
(https://pubmed.ncbi.nlm.nih.gov/), the Online Mendelian
Inheritance of Man (OMIM, www.omim.org), the International Mouse Strain Resource (IMSR, http://www.findm
ice.org/), the Mouse Genome Informatics (MGI, http://
www.informatics.jax.org/), and the International Mouse
Phenotyping Consortium (IMPC, https://w ww.m ouse
phenotype.org/). Together with the MMRRC these organizations represent a large share of commonly used entry
points for identification of mouse models. For example,
all Centers participate in the archiving and distribution
of knockout mouse models generated by the NIH Knockout Mouse Production and Phenotyping (KOMP2) Project (https://commonfund.nih.gov/komp2) (Bradley 2012;

Birling 2021). In coordination with its global partners,
KOMP2 is working to produce and phenotype mouse
lines of male and female mice expressing null alleles for
every human orthologous gene in the mouse genome. The
MMRRC Program is now the primary archive and distribution repository for all KOMP2 products, including mice,
germplasm, ES cells, targeting vectors, and tissue samples.
Investigators seek out these popular knockout mouse lines
available at a nominal cost, which is much simpler and
faster than making them again in their own laboratories.
In addition, the MMRRC Program actively integrates
with resources and providers of other animal species to promote scientific advances benefiting human health. For example, the MMRRC Program shares its mouse phenotype and
genotype data with the MONARCH Initiative (McMurry
2016) to enable semantically integrated computational analysis across mouse and other research animal species that
improves understanding the pathophysiology and genetics
of human disease. These activities are essential to maximize
the application of knowledge gained from studying mouse
models to inform and improve human health.

Technology transfer
The MMRRC Program has developed online Conditions of
Use (COU) and Material Transfer Agreement (MTA) forms
that are used for transferring mouse stocks into and out of
the Centers. These documents have been developed after
input from the community, with the Center’s host institutional officials, and with NIH technology transfer officers.
The paperless COU and Donor MTA are designed to be
time-efficient and eco-friendly, paperless forms. The Donor
MTA can be printed if electronic signatures are not acceptable to a donating institution. All documents must be signed
by an authorized Technology Transfer representative from
the requesting or donating institution, and where applicable
counter-signed by a designated Center official before the
submission or request is processed. The MMRRC Program
facilitates distribution of mice and materials not only to academic users but also to other non-profit and commercial,
for-profit entities such as the biotechnology and biopharmaceutical sectors.

Rigor, reproducibility, and transparency
Although reproducibility of experimental studies using
mice has improved significantly from earlier (Perrin 2014),
centralized mouse repository systems remain a critical
and essential component to ensure the reliability of mouse
models for biomedical research. The MMRRC Program is a
critical component of the NIH’s initiative to optimize rigor,
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reproducibility and transparency in biomedical research that
uses mouse models (Lloyd 2015). Centers in the MMRRC
Consortium are committed to upholding the highest standards of experimental design and quality control to optimize
the reproducibility of research studies using mutant mice.
For example, understanding, documenting, and accurately
reporting the genetic backgrounds of mouse models used in
research is essential for recreating an experimental study and
achieving reproducible results. Specific quality control and
assurance testing processes, such as full genetic annotation
and documentation of each MMRRC mouse, are in place at
each Center. Also, as all Centers have committed to maintaining specific-pathogen-free vivaria and quality control
measures, investigators can rely on mice obtained from the
Centers to generate reproducible results. Specifically, the
Centers address the NIH’s focus on rigor, reproducibility,
and transparency by adhering to the following principles:
• Scientific Premise—the MMRRC Program provides

genetically engineered mouse models for virtually every
field of biomedical research ranging from neurobiology
to infectious disease. These mouse models are critical to
the advancement of understanding of health and disease.
• Rigorous Experimental Design—the MMRRC Provides
authentic and key biological resources that are easily
reported and described using unique identifiers (e.g.,
RRID numbers) to ensure full transparency so that others may obtain the same models with which to reproduce
studies.
• Consideration of Relevant Biological Variables—models
obtained from Centers in the MMRRC Consortium are
genetically defined (including background strain genetics, incipient congenic strains and congenic strains) and
confirmed specific pathogen free. Moreover, individual
Centers have extensive expertise in troubleshooting
how other biological variables, such as husbandry factors, microbiota and sex, may modulate phenotypes. By
obtaining mice from the MMRRC Program, investigators
eliminate the risk of genetic drift or contamination with
adventitious pathogens that potentially can arise through
the use of long standing in-house colonies or obtaining
mice from colleagues. In addition, the MMRRC Program supports the NC3R’s ARRIVE (Animal Research:
Reporting of In Vivo Experiments, https://arriveguid
elines.o rg/) initiative to improve the reporting of research
using animals (Kilkenny 2010). The MMRRC Program
stands behind and supports efforts with 3R development, training, and advances and adheres to standardized
reporting guidelines.
• Authentication of Mice Using the Strain Detail Sheet.
Genetic, phenotypic, husbandry, and other scientific and
research-relevant information on each mutant mouse line
accepted by the MMRRC Program is documented on the
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MMRRC Strain Detail Sheet (SDS). Each mouse line has a
unique SDS page where information provided by the donating investigator, such as specific information curated by the
ICSC, relevant genotyping protocols and specifics about
husbandry, care, and management can be found. In addition, users can find information on availability and prices,
including fees for shipping and handling, for available
product items. The online request form can be accessed
directly from a mouse line’s SDS page.
• Moving Rigor and Reproducibility Forward. The MMRRC
Program is at the forefront of developing and implementing novel broad-based strategies to optimize rigor and
reproducibility of research using mouse models. Two key
examples are (1) the development, refinement and application of miniMUGA for the assessment and confirmation of background strain/substrain of mutant mice and
(2) investment in studies designed to understand the role
of microbiota on model phenotypes and to develop tools
that aid investigators in considering microbiota in model
reproducibility troubleshooting and optimization. Centers
in the MMRRC Consortium have adopted the highest quality control standards to ensure the fidelity and reliability
of mouse models they distribute. As stated previously, all
incoming lines undergo verification and characterization
by a thorough physical exam by trained technicians conducting noting morphological observations, gene-specific
genotyping of DNA extracted from tail snips, background
strain analysis using miniMUGA genome-wide genotyping, 16s gut microbiome analysis, and pathogen surveillance via microbiological culture, PCR, and examination
for parasites. Breeding performance, fertility, viability, and
sexual dimorphism is noted and recorded while verifying
the recoverability of newly cryopreserved germplasm.
If not already available, a newly deposited mouse line is
assigned a unique RRID number and listed with its full
descriptive characteristics, use protocols, and available
formats in the online catalog, linked to scientific references and associated databases. Upon request, a Center
will attempt to recapitulate research-relevant phenotypes
indicated by the submitting investigator, and importantly
reveal any new or previously unknown phenotypes. When
requested as live mice, strains are rederived and maintained
in dedicated vivaria with strict pathogen control systems in
place to prevent contamination by adventitious pathogens.

Disaster planning to preserve and protect
from catastrophic loss
Considering the steep investment over time, the scientific
and unique value of the resource, and operating principles
that minimize duplicative effort and redundant spending to
maintain mutant mouse lines for distribution at more than

The Mutant Mouse Resource and Research Center (MMRRC): the NIH‑supported National Public…

one site, Centers in the MMRRC Consortium have made
strategic investments to minimize losses in the event of
unforeseen disasters, such as loss of power, fire, flooding, or
data breach. For example, Centers split their frozen archive
between different tanks and geographic sites, including at
the National Animal Germplasm Program (NAGP) which
is a part of the National Laboratory for Genetic Resources
Preservation (NLGRP) located in Fort Collins, Colorado,
USA (Kaplan 2016). Electrical power supplying the vivaria,
storage tanks, and data servers are provided full 100%
backup using dedicated electrical generators. Fire suppression systems are in place and monitored 24/7/365 by host
institution security services, and systems are regularly tested
to verify functionality. All data servers are monitored by
online cloud services and monthly backups (e.g., tape) are
made and stored at distant secure sites for complete data
restoration if needed. These and other security practices
ensure the preservation of the resource and shared between
all Centers in the MMRRC Consortium.

Resource sharing plan
The MMRRC Program was also established as a means to
implement the NIH Sharing Plans for Resources and Data.
Its prime directive is to encourage submission and deposition of unique mutant mouse resources developed through
NIH-sponsored research into the MMRRC Program from
where they are made readily available to scientists qualified
and approved by their institutions to use mice for research
purposes. The ICSC makes all mouse resources and genotype, health, husbandry information, phenotype, and other
relevant data (including meta-analysis data) available on the
SDS. Submitted data are confirmed with relevant data and
terminology standards. All data are made publicly available
after curation, assignment of an RRID number, and listing
the strain in the MMRRC online catalog, usually within
30 days of receipt of information and mice from the submitting investigator. The ICSC provides investigators with
standard language to include in publications that identify
where mutant mice and data are available, how to access
data on the MMRRC Program website (www.mmrrc.org),
and how to acknowledge the MMRRC Program and NIH
funding source.

The future of the MMRRC program
The MMRRC Program will continue its active leadership
and engagement as the leading public national mouse repository system in the USA. This includes continuing emphasis
on providing research scientists with the most appropriate,
valid, and reliable mutant mouse models and services using
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next-generation technologies (e.g., CRISPR) for well-justified, scientifically sound, and reproducible research.
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